Terms: = Pancreatic cancer AND KMT2D, ENSG00000167548, 8085, MLL2
41 results:
1. Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma.
Yang X; Lian B; Zhang N; Long J; Li Y; Xue J; Chen X; Wang Y; Wang Y; Xun Z; Piao M; Zhu C; Wang S; Sun H; Song Z; Lu L; Dong X; Wang A; Liu W; Pan J; Hou X; Guan M; Huo L; Shi J; Zhang H; Zhou J; Lu Z; Mao Y; Sang X; Wu L; Yang X; Wang K; Zhao H
BMC Med; 2024 Jan; 22(1):42. PubMed ID: 38281914
[TBL] [Abstract] [Full Text] [Related]
2. Successful immunotherapy with PD-1 Iinhibitor for advanced pancreatic cancer: report of two cases and review of literature.
Qiu L; Liu C; Li H
Anticancer Drugs; 2024 Mar; 35(3):263-270. PubMed ID: 38194502
[TBL] [Abstract] [Full Text] [Related]
3. The genomic and immune landscapes of gastric cancer and their correlations with HER2 amplification and PD-L1 expression.
Jing X; Luo Z; Wu J; Ye F; Li J; Song Z; Zhang Y; Shi M; Sun H; Fang Y; Jiang Y; Ji X
Cancer Med; 2023 Dec; 12(24):21905-21919. PubMed ID: 38050871
[TBL] [Abstract] [Full Text] [Related]
4. EBF2 Links kmt2d-Mediated H3K4me1 to Suppress pancreatic cancer Progression via Upregulating KLLN.
Yao B; Xing M; Meng S; Li S; Zhou J; Zhang M; Yang C; Qu S; Jin Y; Yuan H; Zen K; Ma C
Adv Sci (Weinh); 2024 Jan; 11(2):e2302037. PubMed ID: 38015024
[TBL] [Abstract] [Full Text] [Related]
5. Genomic profile and clinical features of MSI-H and TMB-high pancreatic cancers: real-world data from C-CAT database.
Sakakida T; Ishikawa T; Doi T; Morita R; Kataoka S; Miyake H; Yamaguchi K; Moriguchi M; Sogame Y; Yasuda H; Iwasaku M; Konishi H; Takayama K; Itoh Y
J Gastroenterol; 2024 Feb; 59(2):145-156. PubMed ID: 38006445
[TBL] [Abstract] [Full Text] [Related]
6. Molecular and Functional Heterogeneity of Primary pancreatic Neuroendocrine Tumors and Metastases.
Guo Y; Tian C; Cheng Z; Chen R; Li Y; Su F; Shi Y; Tan H
Neuroendocrinology; 2023; 113(9):943-956. PubMed ID: 37232011
[TBL] [Abstract] [Full Text] [Related]
7. kmt2d links TGF-β signaling to noncanonical activin pathway and regulates pancreatic cancer cell plasticity.
Lu S; Kim HS; Cao Y; Bedi K; Zhao L; Narayanan IV; Magnuson B; Gu Y; Yang J; Yi Z; Babaniamansour S; Shameon S; Xu C; Paulsen MT; Qiu P; Jeyarajan S; Ljungman M; Thomas D; Dou Y; Crawford H; di Magliano MP; Ge K; Yang B; Shi J
Int J Cancer; 2023 Aug; 153(3):552-570. PubMed ID: 37140208
[TBL] [Abstract] [Full Text] [Related]
8. Multi-omics analyses of MEN1 missense mutations identify disruption of menin-MLL and menin-JunD interactions as critical requirements for molecular pathogenicity.
Dreijerink KMA; Ozyerli-Goknar E; Koidl S; van der Lelij EJ; van den Heuvel P; Kooijman JJ; Biniossek ML; Rodenburg KW; Nizamuddin S; Timmers HTM
Epigenetics Chromatin; 2022 Aug; 15(1):29. PubMed ID: 35941657
[TBL] [Abstract] [Full Text] [Related]
9. A Case Report of MODY
Li TL; Ding HX; Zhao XL; Luo J; Chen K; Tang Z; Huang LY; Li LB; Yang L
Chin Med Sci J; 2022 Jun; 37(2):167-170. PubMed ID: 35796342
[TBL] [Abstract] [Full Text] [Related]
10. Whole-exome sequencing analysis of NSCLC reveals the pathogenic missense variants from cancer-associated genes.
Kumar S U; Balasundaram A; Cathryn R H; Varghese RP; R S; R G; Younes S; Zayed H; Doss C GP
Comput Biol Med; 2022 Sep; 148():105701. PubMed ID: 35753820
[TBL] [Abstract] [Full Text] [Related]
11. Molecular Subgroups of Intrahepatic Cholangiocarcinoma Discovered by Single-Cell RNA Sequencing-Assisted Multiomics Analysis.
Bao X; Li Q; Chen J; Chen D; Ye C; Dai X; Wang Y; Li X; Rong X; Cheng F; Jiang M; Zhu Z; Ding Y; Sun R; Liu C; Huang L; Jin Y; Li B; Lu J; Wu W; Guo Y; Fu W; Langley SR; Tano V; Fang W; Guo T; Sheng J; Zhao P; Ruan J
Cancer Immunol Res; 2022 Jul; 10(7):811-828. PubMed ID: 35604302
[TBL] [Abstract] [Full Text] [Related]
12. Genomic landscape of microsatellite instability in Chinese tumors: A comparison of Chinese and TCGA cohorts.
Li Z; Jia Y; Zhu H; Yuan H; Xing X; Xin Y; Ma T; Pang F; Zhang Y; Hu Y; Jia S; Ji J
Int J Cancer; 2022 Oct; 151(8):1382-1393. PubMed ID: 35567574
[TBL] [Abstract] [Full Text] [Related]
13. Molecular Characterization of KRAS Wild-type Tumors in Patients with pancreatic Adenocarcinoma.
Philip PA; Azar I; Xiu J; Hall MJ; Hendifar AE; Lou E; Hwang JJ; Gong J; Feldman R; Ellis M; Stafford P; Spetzler D; Khushman MM; Sohal D; Lockhart AC; Weinberg BA; El-Deiry WS; Marshall J; Shields AF; Korn WM
Clin Cancer Res; 2022 Jun; 28(12):2704-2714. PubMed ID: 35302596
[TBL] [Abstract] [Full Text] [Related]
14. The low-complexity domains of the kmt2d protein regulate histone monomethylation transcription to facilitate pancreatic cancer progression.
Li W; Wu L; Jia H; Lin Z; Zhong R; Li Y; Jiang C; Liu S; Zhou X; Zhang E
Cell Mol Biol Lett; 2021 Nov; 26(1):45. PubMed ID: 34758724
[TBL] [Abstract] [Full Text] [Related]
15. Treatment landscape of metastatic pancreatic cancer.
De Dosso S; Siebenhüner AR; Winder T; Meisel A; Fritsch R; Astaras C; Szturz P; Borner M
Cancer Treat Rev; 2021 May; 96():102180. PubMed ID: 33812339
[TBL] [Abstract] [Full Text] [Related]
16. Deep Targeted Sequencing and Its Potential Implication for cancer Therapy in Chinese Patients with Gastric Adenocarcinoma.
Yu P; Wang Y; Yu Y; Wang A; Huang L; Zhang Y; Liu W; Wu H; Yao M; Du YA; Cheng X
Oncologist; 2021 May; 26(5):e756-e768. PubMed ID: 33511732
[TBL] [Abstract] [Full Text] [Related]
17. Management of Very Late pancreatic Metastasis of Renal Cell Carcinoma 8 Years After Radical Nephrectomy: A Report of a Rare Case.
Alayyaf N; AlQatari AA; Altalib A; AlQattan AS; Alshahrani AA
Am J Case Rep; 2021 Jan; 22():e927921. PubMed ID: 33400693
[TBL] [Abstract] [Full Text] [Related]
18. Genetic characteristics of gastric-type mucinous carcinoma of the uterine cervix.
Park E; Kim SW; Kim S; Kim HS; Lee JY; Kim YT; Cho NH
Mod Pathol; 2021 Mar; 34(3):637-646. PubMed ID: 32641744
[TBL] [Abstract] [Full Text] [Related]
19. Identification of germline and somatic mutations in pancreatic adenosquamous carcinoma using whole exome sequencing.
Ma H; Song B; Guo S; Li G; Jin G
Cancer Biomark; 2020; 27(3):389-397. PubMed ID: 31958074
[TBL] [Abstract] [Full Text] [Related]
20. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
[Next]
